Jae Kim
Director Técnico/Científico/I+D en DESIGN THERAPEUTICS, INC. .
Fortuna: 17 883 $ al 30/04/2024
Perfil
Jae B.
Kim is currently the Chief Medical Officer at Design Therapeutics, Inc. Prior to this, he was the Chief Medical Officer at Avidity Biosciences, Inc. from 2020 to 2021 and the Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2016 to 2020.
Dr. Kim received his undergraduate degree from Cornell University and his doctorate from Weill Cornell Medical College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
13/03/2024 | 4 756 ( 0.01% ) | 17 883 $ | 30/04/2024 |
Cargos activos de Jae Kim
Empresas | Cargo | Inicio |
---|---|---|
DESIGN THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/02/2022 |
Antiguos cargos conocidos de Jae Kim.
Empresas | Cargo | Fin |
---|---|---|
AVIDITY BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 30/08/2021 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2020 |
Formación de Jae Kim.
Cornell University | Undergraduate Degree |
Weill Cornell Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
AVIDITY BIOSCIENCES, INC. | Health Technology |
DESIGN THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Jae Kim